Taiwan Liposome Company, Ltd.c Stock Price, News & Analysis

TLC NASDAQ

Company Description

Taiwan Liposome Company, Ltd.c (NASDAQ: TLC) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

TLC stock has gained 53.9% over the past year.

This page provides a comprehensive overview of TLC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+53.85%

Performance 1 year

$0.0

Market Cap

42.1M

Shares outstanding

Taiwan Liposome Company, Ltd.c (TLC) stock. Over the past 12 months, the stock has gained 53.9%.

Latest News

View All

November 20, 2023

—

Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

November 8, 2023

—

TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

conferences clinical trial

June 13, 2022

—

TLC Announces TLC599 Agreement with Endo

March 7, 2022

—

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

clinical trial

September 8, 2021

-2.72%

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

August 12, 2021

+0.85%

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

earnings

Taiwan Liposome Company, Ltd.c has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences, clinical trial, earnings, covid-19. View all TLC news →

SEC Filings

View All

No SEC filings available for TLC.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

TLC Company Profile & Sector Positioning

Taiwan Liposome Company, Ltd.c (TLC) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.